Insider · CIK 0001853544
Alan Edmund Walts
Files at ELOX (Eloxx Pharmaceuticals, Inc.). First filing -, latest -.
Alan Edmund Walts files SEC Form 4 as director at ELOX (Eloxx Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alan Edmund Walts has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 24, 2025 | ELOX Eloxx Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,750 | $0.00 | $0 | 16,692 | Jan 28, 2025 |
| Jan 24, 2025 | ELOX Eloxx Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,750 | $0.00 | $0 | 3,750 | Jan 28, 2025 |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | AGrant or award Common Stock | +12,000 | $0.00 | $0 | 12,942 | Oct 17, 2024 |
Questions about Alan Edmund Walts
Answered from the filings on this page, as of the latest one.
Is Alan Edmund Walts buying or selling?
Alan Edmund Walts has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alan Edmund Walts's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alan Edmund Walts has 0.
Where does Alan Edmund Walts file Form 4?
Alan Edmund Walts has filed Form 4 at ELOX (Eloxx Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.